Sat.Jul 02, 2022 - Fri.Jul 08, 2022

10 clinical trials to watch in the second half of 2022

Bio Pharma Dive

The biotech industry's downturn accelerated in the first half of the year. Important study readouts for Eisai, Gilead, Merck and Seagen, among others, could determine whether the slump will endure

AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes

World of DTC Marketing

In 2020, over 75% of AbbVie’s’ sales were made to American consumers, yet only 1% of AbbVie’s’ income was reported in the United States for tax purposes.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Is biotech facing a long bear market?

Pharmaceutical Technology

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence.

Addressing Rising Rx Costs

Pharmaceutical Commerce

How did the industry get here and what alternatives can be sought out?


2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy

Bio Pharma Dive

The decision by U.S. regulators is the latest boost for a company whose shares have climbed more than 30% during the biotech sector’s worst downswing in years

Misjustice benefits pharma

World of DTC Marketing

Endpoint News reported “Three major drug distributors are off the hook for what may have been a $2.5 billion payment after a federal judge found them not liable for the opioid epidemic in parts of West Virginia, one of the hardest-hit areas of the country.

More Trending

Thermo Fisher Scientific Declares Quarterly Dividend

BioTech 365

Thermo Fisher Scientific Declares Quarterly Dividend Thermo Fisher Scientific Declares Quarterly Dividend WALTHAM, Mass.–(BUSINESS –(BUSINESS WIRE)–Thermo Fisher Scientific Inc.


Two cancer biotechs merge, raise cash as sector-wide downturn continues

Bio Pharma Dive

Syros Pharmaceuticals and Tyme Technologies, shares of which trade near all-time lows, will combine and raise about $130 million from private investors to stay afloat


Getting an Rx does not address health problems

World of DTC Marketing

Imagine a medicine that reduced the death rate of breast cancer and risk of recurrent breast cancer by 50% lowered the risks of colon cancer and type 2 diabetes by two-thirds, and those of heart disease, hypertension, and Alzheimer’s’ disease by 40%.

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Cancer Drug Greatly Reduces Deaths in Hospitalized Covid Patients

NY Times

A new study found that sabizabulin reduced the risk of death by 55 percent, but some experts were cautious about overinterpreting the results. Coronavirus Risks and Safety Concerns Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Clinical Trials Deaths (Fatalities) your-feed-healthcare sabizabulin

Drugs 82

With $100M AstraZeneca deal, a biotech and its investors engineer another buyout

Bio Pharma Dive

An entity originally known as Teneobio has now been the focus of three acquisition deals with large pharmaceutical companies since 2021, capitalizing on the industry’s growing interest in dual-acting antibody drugs

Fast and facile synthesis of antibacterial amino acid Schiff base copper complexes


Ever since their development in the late 19th century, Schiff bases have been a popular group of organic compounds, owing to their wide variety of desirable properties.

Brii Bio acquires Vir’s antibody rights for Hepatitis B in Greater China

Pharmaceutical Technology

Brii Biosciences (Brii Bio) has exercised an option for the acquisition of exclusive development and marketing rights for Vir Biotechnology’s investigational antibody, VIR-3434, for Hepatitis B in Greater China, under a partnership agreement.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Researchers: Improving Eyesight May Help Prevent Dementia

NY Times

As experimental drugs prove ineffective against increasing dementia cases in the U.S., researchers argue that improving eyesight can have an effect.

After a lengthy drought, could biotech M&A be on the upswing?

Bio Pharma Dive

With at least 14 buyouts worth $50 million or more, the second quarter was one of the busiest three-month periods for acquisitions in recent years. Some industry watchers expect that pace to continue


Universal influenza B vaccine induces broad, sustained protection, biomedical sciences researchers find


ATLANTA—A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

Brii Bio introduces Covid-19 combination therapy in China

Pharmaceutical Technology

Brii Biosciences and TSB Therapeutics have commercially launched a long-acting neutralising antibody therapy combination, amubarvimab/romlusevimab, for Covid-19 in China.

The Quest by Circadian Medicine to Make the Most of Our Body Clocks

NY Times

Researchers are trying to figure out the right hour of the day to do everything. Can their studies sync us up with better health? Sleep Genetics and Heredity Biorhythms Drugs (Pharmaceuticals) Preventive Medicine Hospitals

Radius, fending off activists, outlines pitch for $890 million buyout

Bio Pharma Dive

The biotech detailed the process that led to its take-private offer last month, aiming to win the support of shareholders, including two firms that have pushed for change


Natural gas is key to WVU engineer’s vision for clean hydrogen energy


More than 50 years after scientists first coined the term “hydrogen economy,” the movement to make hydrogen a predominant global fuel source could be gaining traction, thanks to research led by one West Virginia University engineer.

EC approves Novavax’s Covid-19 vaccine CMA expansion for adolescents

Pharmaceutical Technology

The European Commission (EC) has granted approval for the expanded conditional marketing authorization (CMA) of Novavax’s Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), in the European Union (EU) for adolescents of the age 12 to 17 years.

Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’


The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies.

Genome 105

FDA, under fire for Aduhelm approval, starts review of another Alzheimer's drug

Bio Pharma Dive

The regulator could clear Biogen and Eisai’s lecanemab by early January. A decision before Phase 3 results could amplify the criticism the agency already faces, however

Two life scientists in Portugal elected as EMBO members


Specialised Therapeutics’ breast cancer drug gets Philippines FDA approval

Pharmaceutical Technology

Specialised Therapeutics’ oral drug, Nerlynx (neratinib) has obtained the Philippines Food and Drug Administration approval to lower the recurrence or mortality risk in early-stage HER2-positive (HER2+) breast cancer patients.

Amid drug pricing debate, feds reveal effort to crack down on 'incremental' patents

Fierce Pharma

Amid drug pricing debate, feds reveal effort to crack down on 'incremental' patents. zbecker. Thu, 07/07/2022 - 10:58

Drugs 104

CureVac sues rival COVID-19 vaccine maker BioNTech for patent infringement

Bio Pharma Dive

The biotech, whose own efforts to develop a COVID-19 vaccine have faltered, claims its inventions were crucial to the development of BioNTech’s top-selling coronavirus shot

NTU Singapore and poultry firm Leong Hup Singapore collaborate to create Singapore’s first ‘zero waste’ poultry processing facility


Nanyang Technological University, Singapore (NTU Singapore) and poultry producer Leong Hup Singapore Pte Ltd have jointly developed processes to repurpose waste materials from poultry farming.

Europe is seeing a hiring boom in pharmaceutical industry data analytics roles

Pharmaceutical Technology

Europe was the fastest growing region for data analytics hiring among pharmaceutical industry companies in the three months ending May. The number of roles in Europe made up 11.8% of total data analytics jobs - up from 11.1% in the same quarter last year.

Bavarian Nordic inks hefty US monkeypox vaccine supply deal for 2.5M doses

Fierce Pharma

Bavarian Nordic inks hefty US monkeypox vaccine supply deal for 2.5M doses. fkansteiner. Tue, 07/05/2022 - 09:02

New analysis encourages Intercept to refile NASH drug for approval

Bio Pharma Dive

The company said the new examination is more “in line” with FDA guidance and still found that its drug, known as OCA, helped reduce liver scarring

Drugs 230

FSU researchers expand understanding of vortex spread in superfluids


An international team of scientists featuring Florida State University researchers has developed a model that predicts the spread of vortices in so-called superfluids, work that provides new insight into the physics that govern turbulence in quantum fluid systems such as superfluid neutron stars.

Cell and gene therapies: why advanced medicines call for specialised logistics

Pharmaceutical Technology

Genetic mutations, both germline and acquired, are behind a large proportion of the most debilitating and sometimes life-threatening human diseases. But scientists have struggled to find effective treatments for many of these diseases since the dawn of modern medicine.